homeostasis/metabolism
N |
• mice exhibit normal serum glycerol and fatty acid
• mice exhibit normal hepatic and muscle lipid content
|
• indicated by increased oxygen consumption
|
• in whole mouse and adipocytes
|
• in mice weighing more than 30 g
|
• in mice weighing more than 30 g
|
• decreased leptin in adipose tissue
|
• in mice weighing more than 30 g after glucose injection
|
• basal free fatty acid release from adipocytes is increased compared to in wild-type mice
|
• basal glycerol release from adipocytes is increased compared to in wild-type mice
• adipocytes treated with denosine deaminase (ADA) and increasing concentrations of (-)-N6-(2-Phenylisopropyl)adenosine (PIA) or rolipram and/or cilostamide exhibit increased glycerol release compared with wild-type cells
• however, isoproterenol-induced lipolysis in adipocytes is normally suppressed by insulin treatment
|
• in the epididymal fat pad of mice fed a standard diet
|
• 2-fold in adipocytes
• in adipocytes stimulated with isoproterenol
• however, isoproterenol-induced lipolysis in adipocytes is normally suppressed by insulin treatment
|
adipose tissue
N |
• mice exhibit normal numbers of adipocytes
|
• in mice fed a standard diet
|
• in the epididymal fat pad of mice fed a standard diet
|
• in mice fed a standard diet
• in fasted mice fed a high-fat diet
|
• in mice fed a standard diet
• in fasted mice fed a high-fat diet
|
• in mice fed a standard diet
|
• adipocytes exhibit enhanced basal and stimulated lipolysis
• basal glycerol and free fatty acid release from adipocytes is increased compared to in wild-type mice
• adipocytes treated with denosine deaminase (ADA) and increasing concentrations of (-)-N6-(2-Phenylisopropyl)adenosine (PIA) or rolipram and/or cilostamide exhibit increased glycerol release compared with wild-type cells
• however, isoproterenol-induced lipolysis in adipocytes is normally suppressed by insulin treatment
|
growth/size/body
N |
• mice exhibit normal body weight on standard chow or a high-fat diet
|